Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yvan.wenger
    Member
    • Aug 2009
    • 30

    #1

    Experimental design with edgeR and DESeq packages

    Hi everybody,

    I just started using edgeR and DESeq and am looking for a confirmation that I am not doing a silly thing.

    Basically, we have 3 conditions and for only 1 of these sample we have biological triplicates. Let us say that the samples are "A", "A", "A", "B" , "C" (most of the genes are NOT regulated in my experiment). Finally, let us say we just want to compare "B" to "C", but using all the information available. Can we use all the dataset for estimating the common and tagwise dispersion? Typically using the commands (note that I compare here "B" to "C", thus samples without replicates).

    edgeR:
    countTable=read.table('mytable',header=F,row.names=1) ; dge <- DGEList(counts=countTable,group=c("A","A","A","B","C")) ; dge <- calcNormFactors(dge) ; dge <- estimateCommonDisp(dge) ; dge <- estimateTagwiseDisp(dge) ; et <- exactTest(dge, pair=c("B","C"))

    or

    DESeq:
    countTable = read.table('mytable.csv', header=F,row.names=1) ; design = data.frame(row.names = colnames(countTable),condition = c("A","A","A","B","C")) ; condition =design$condition ;cds=newCountDataSet(countTable,condition) ; cds=estimateSizeFactors(cds);cds=estimateDispersions(cds) res=nbinomTest(cds,"B","C")

    Is it ok to do so (to use samples not compared in the end to estimate the dispersion) Does this correspond to the example "working partially without replicates" from the DESeq manual) ? Or should I just consider that there is no replicates for sample B and C and proceed by ignoring other samples completely ?

    Many thanks !

    Yvan

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...